Your browser doesn't support javascript.
loading
Who is hesitant about Covid-19 vaccines? The profiling of participants in a French online cohort.
Montagni, Ilaria; Ouazzani-Touhami, Kevin; Pouymayou, Aude; Pereira, Edwige; Texier, Nathalie; Schück, Stéphane; Tzourio, Christophe.
Afiliación
  • Montagni I; Univ.Bordeaux, Inserm, Bordeaux Population Health Research Center, U1219, F-33000, Bordeaux, France. Electronic address: ilaria.montagni@u-bordeaux.fr.
  • Ouazzani-Touhami K; Univ.Bordeaux, Inserm, Bordeaux Population Health Research Center, U1219, F-33000, Bordeaux, France; Polyclinique Inkermann, groupe Elsan, 79000 Niort, France.
  • Pouymayou A; Univ.Bordeaux, Inserm, Bordeaux Population Health Research Center, U1219, F-33000, Bordeaux, France.
  • Pereira E; Univ.Bordeaux, Inserm, Bordeaux Population Health Research Center, U1219, F-33000, Bordeaux, France.
  • Texier N; Kap Code, F-75010 Paris, France; Kappa Santé, F-75002 Paris, France.
  • Schück S; Kap Code, F-75010 Paris, France; Kappa Santé, F-75002 Paris, France.
  • Tzourio C; Univ.Bordeaux, Inserm, Bordeaux Population Health Research Center, U1219, F-33000, Bordeaux, France.
Rev Epidemiol Sante Publique ; 70(3): 123-131, 2022 Jun.
Article en En | MEDLINE | ID: mdl-35428543
OBJECTIVES: To report the characteristics of vaccine-hesitant individuals in a French-speaking adult population in the context of the SARS-CoV-2 pandemic; and to identify predictors of hesitancy about Covid-19-related vaccines. METHODS: Between April and May 2020, 1640 French-speaking adults participating in an online cohort were classified according to their attitudes towards vaccination as: "hesitant", "anti-vaccination", and "pro-vaccination". Descriptive statistics, univariate multinomial regression models and multivariate analyses were compiled and carried out. RESULTS: At the time of inclusion, compared to pro-vaccination participants, hesitant participants were more frequently females (p=0.044), not annually vaccinated against flu (p=0.026), less optimistic about the discovery of a treatment against Covid-19 in a few months (p<0.001), less ready to undergo this treatment (p<0.001), presenting less trust in the ability of public health authorities to control the pandemic (p=0.036) and reporting lower scores on knowledge-related scales (p values from <0.001 to 0.002). Univariate analyses confirmed these results with odds ratios ranging from 1.51 [1.05-2.17] to 2.19 [1.56-3.07]. In the multivariate models, the remaining variables associated with hesitant compared to pro-vaccination attitudes were discovery of a treatment against Covid-19 in a few months (OR=2.57 [1.73-3.81]), being ready to undergo this treatment (OR=7.07 [4.89-10.22]), digital vaccine literacy (OR=1.70 [1.14-2.54]) and general health literacy (OR=1.49 [1.03-2.15]). DISCUSSION: In a continuum of relative acceptance of Covid-19-related vaccines, hesitant individuals were situated in between the behaviours and characteristics of pro-vaccination and anti-vaccination groups. While their characteristics were in line with the literature, this study was the first to report data on health literacy, digital vaccine literacy and capacity to detect fake news associated with vaccine hesitancy. CONCLUSIONS: While failing to identify straightforward predictors, findings suggest that continued education and communication campaigns focused on improving vaccine literacy, particularly among women younger than 35 years, could heighten the proportion of persons accepting vaccination.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas / COVID-19 Tipo de estudio: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans Idioma: En Revista: Rev Epidemiol Sante Publique Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas / COVID-19 Tipo de estudio: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans Idioma: En Revista: Rev Epidemiol Sante Publique Año: 2022 Tipo del documento: Article